101409-58-9

Basic information

• Product Name: (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol
• Synonyms: (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol;Salvicanol
• CAS NO: 101409-58-9
• Molecular Formula: C₂₁H₃₂O₃
• Molecular Weight: 332.47698
• Mol File: 101409-58-9.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol(CAS DataBase Reference)
• NIST Chemistry Reference: (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol(101409-58-9)
• EPA Substance Registry System: (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol(101409-58-9)

Safety Data

• Hazardous Substances Data: 101409-58-9(Hazardous Substances Data)

Usage

Description

(10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol is a complex chemical compound derived from the sesquiterpene class of natural products. It features a cycloabieta-8,11,13-triene backbone with a methoxy group at the 12th position and hydroxyl groups at the 10th and 11th positions. (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol possesses potential biological and pharmacological activities, making it a candidate for various medicinal and therapeutic applications. However, further research is necessary to fully comprehend its properties and potential uses.

Uses

Used in Pharmaceutical Industry:
(10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol is used as a pharmaceutical compound for its potential biological and pharmacological activities. Its unique structure and functional groups may contribute to the development of new drugs and therapies.
Used in Medicinal Research:
In the field of medicinal research, (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol serves as a subject for investigation. Scientists are exploring its potential applications in treating various diseases and conditions, as well as understanding its interactions with biological systems.
Used in Drug Development:
(10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol is utilized in drug development to create novel therapeutic agents. Its unique chemical structure may offer new avenues for the treatment of diseases and the enhancement of existing medications.
Note: The specific applications and industries for (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol are not explicitly mentioned in the provided materials. The uses listed above are inferred based on the compound's potential biological and pharmacological activities and its classification as a sesquiterpene natural product. Further research and development are required to determine the exact applications and industries where this compound can be effectively utilized.

Upstream product

• 139471-06-0 (4aS,11aS)-8-Isopropyl-6,7-dimethoxy-1,1-dimethyl-1,2,3,4,5,10,11,11a-octahydro-dibenzo[a,d]cyclohepten-4a-ol 

Relevant articles and documents

Collective Syntheses of Icetexane Natural Products Based on Biogenetic Hypotheses

A divergent synthesis of 10 icetexane natural products based on a proposed biogenetic cationic ring expansion of a reduced carnosic acid derivative is described. Of these icetexanes, (+)-salvicanol, (?)-cyclocoulterone, (?)-coulterone, (?)-obtusinone D, and (?)-obtusinone E have been synthesized for the first time. In addition, the hypothesis for the non-enzymatic biogenesis of benzo[1,3]dioxole natural products has been experimentally investigated. Additional experimental evidence for the abiotic formation of the methylenedioxy unit is provided, as photolysis of the quinone (+)-komaroviquinone resulted in the formation of the [1,3]dioxole-containing natural product (?)-cyclocoulterone and (+)-komarovispirone.